Coenzyme Q10 100 mg

Coenzyme Q10 100 mg

Source Naturals4.8 (1,658 ratings)
Format:Capsule Quantity: 60 Capsule(s) · 60 servings
Goals
$14.26 $0.23 per serving

Product analysis

75 out of 100

Coenzyme Q10 100 mg offers a focused, affordable source of CoQ10 with limited evidence for supporting blood-vessel function. Benefits for everyday energy remain uncertain in healthy adults.

AI assessment of the formula, label and price. How scoring works

Nutrient Quality40

The ubiquinone form is clearly named. A quality advantage over other CoQ10 forms has not been established.

Ingredient Transparency100

The CoQ10 amount and ubiquinone form are both disclosed. That makes it easy to compare the serving with other options.

Value For Money100

The cost is favorable for the amount of ubiquinone supplied. It offers good value for buyers seeking CoQ10 alone.

Customer Satisfaction86

Customer feedback is highly favorable across more than a thousand ratings. Those reviews provide satisfaction context without proving cardiovascular or energy benefits.

Product Focus70

The single-ingredient formula concentrates on CoQ10 across related goals. Blood-vessel findings are limited, while energy and aging benefits depend on context and preparation.

Format
Capsule
Container
60 Capsule(s)
Per serving
$0.23
Customer rating
4.8 · 1,658 ratings
Report analysis

Goals

Heart Health
Impact
Highest effect
A- Ingredient FitD+ PathwaysA+ EvidenceA+ Formulation Logic
Coenzyme Q-10 · 100 mg

CoQ10 may offer limited support for blood-vessel function and blood pressure, based on small trials in selected populations. This product declares conventional active CoQ10, which has its own exposure comparison. A single serving does not establish the repeated use studied in trials, and these findings do not establish routine prevention of cardiovascular events.

How this product is rated for Heart Health

Ingredient fit86

CoQ10 provides the main recognized connection. CoQ10 provides partial exposure coverage; the serving amounts do not establish an effective daily regimen.
Goal fit
CoQ10 is the main recognized focus.
Dose adequacy
CoQ10 provides partial exposure coverage; the serving amounts do not establish an effective daily regimen.

Pathways53

The breadth finding centers on blood-vessel function, rather than broad coverage of different heart-health functions.
Depth
The main recognized connection is blood-vessel function.
Breadth
The breadth finding centers on blood-vessel function, rather than broad coverage of different heart-health functions.

Evidence98

CoQ10 has limited vascular evidence from small trials in selected populations.
Evidence strength
CoQ10 has limited vascular evidence from small trials in selected populations.
Studied preparation
The saved preparation check recognizes the counted declarations, without establishing product-specific trial results.

Formulation logic100

No missing required partner or configured conflict was identified. All ingredients counted for this check meet its minimum exposure criterion; that criterion does not prove clinical benefit.
Partner coverage
No missing required partner was identified among the counted ingredients; this does not imply additional benefit from combining them.
Conflicts
No configured ingredient conflict was identified in the supplied facts.
Effective doses
All ingredients counted for this check meet its minimum exposure criterion; that criterion does not prove clinical benefit.
Study evidence
Longevity
Impact
Moderate effect
B- Ingredient FitF PathwaysF EvidenceA+ Formulation Logic
Coenzyme Q-10 · 100 mg

CoQ10 contributes to mitochondrial energy production and antioxidant defence. The 100 mg amount provides partial exposure support; the supplied visible skin-aging results apply to a specific water-soluble preparation.

How this product is rated for Longevity

Ingredient fit73

The counted ingredients are closely aligned with the aging-related functions assessed here. The counted amounts provide partial exposure support.
Goal fit
The counted ingredients are closely aligned with the aging-related functions assessed here.
Dose adequacy
The counted amounts provide partial exposure support.

Pathways10

The strongest supported mechanism is mitochondrial energy production, with limited coverage. No mechanism reaches the saved coverage target.
Depth
The strongest supported mechanism is mitochondrial energy production, with limited coverage.
Breadth
No mechanism reaches the saved coverage target.

Evidence30

Coenzyme Q-10 provides the strongest evidence contribution among ingredients counted at a sufficient amount, within the limited outcomes supplied. The counted preparation is not matched to the preparation used in the relevant supplied trials.
Evidence strength
Coenzyme Q-10 provides the strongest evidence contribution among ingredients counted at a sufficient amount, within the limited outcomes supplied.
Studied preparation
The counted preparation is not matched to the preparation used in the relevant supplied trials.

Formulation logic100

The counted ingredients can contribute independently or have their required partner. No configured ingredient conflict was identified in the supplied findings. 1 of 1 counted ingredients meet the saved minimum exposure threshold.
Partner coverage
The counted ingredients can contribute independently or have their required partner.
Conflicts
No configured ingredient conflict was identified in the supplied findings.
Effective doses
1 of 1 counted ingredients meet the saved minimum exposure threshold.
Study evidence
Energy
Impact
High effect
B- Ingredient FitF PathwaysB+ EvidenceA+ Formulation Logic
Coenzyme Q-10 · 100 mg

CoQ10 participates in mitochondrial energy production, and this product identifies the ubiquinone form. The supplied evidence supports only limited, preparation-specific fatigue relief; results in clinical disease groups do not establish a routine energy increase in healthy adults. The 100 mg serving makes a partial amount contribution in the saved findings.

How this product is rated for Energy

Ingredient fit73

The 100 mg ubiquinone serving contributes partially against the supplied amount reference.
Goal fit
CoQ10 keeps the counted formula focused, while its links to other goals limit how specifically it targets energy.
Dose adequacy
The 100 mg ubiquinone serving contributes partially against the supplied amount reference.

Pathways17

The main contribution is concentrated in mitochondrial energy production, with partial coverage rather than demonstrated improvement across all forms of fatigue.
Depth
The main contribution is concentrated in mitochondrial energy production, with partial coverage rather than demonstrated improvement across all forms of fatigue.
Breadth
No named energy category reaches the saved breadth threshold.

Evidence84

CoQ10 supplies the evidence contribution, with limited preparation-specific fatigue findings and restricted transfer from clinical populations.
Evidence strength
CoQ10 supplies the evidence contribution, with limited preparation-specific fatigue findings and restricted transfer from clinical populations.
Studied preparation
Ubiquinone is explicitly identified; no absorption-superiority advantage is established.

Formulation logic100

The counted ingredients have no missing partner requirement or identified conflict. Their amounts meet the saved minimum counting criterion.
Partner coverage
The counted ingredients have no unmet partner requirement in the supplied findings.
Conflicts
No matched ingredient conflict was identified in the supplied findings.
Effective doses
All counted ingredients reach the saved minimum amount criterion; this is not a proven threshold for fatigue relief.
Study evidence
Cardiovascular Support
Impact
Highest effect
A- Ingredient FitD+ PathwaysA- EvidenceA+ Formulation Logic
Coenzyme Q-10 · 100 mg

Coenzyme Q10 may support blood-vessel lining function and some blood-pressure or lipid markers, based on limited studies in adults with abnormal lipids. This product supplies 100 mg of ubiquinone per serving, making it a focused contribution near the supplied study exposure. The evidence does not establish prevention of heart attacks or strokes, or superiority of this form.

How this product is rated for Cardiovascular Support

Ingredient fit86

A focused CoQ10 formula.
Goal fit
A focused CoQ10 formula.
Dose adequacy
The declared 100 mg serving provides a substantial contribution within the saved amount comparison.

Pathways53

Blood-vessel lining function dominate the saved findings; this describes mechanisms rather than proven prevention of cardiovascular events.
Depth
Blood-vessel lining function provide the main represented mechanism.
Breadth
Only one mechanism meets the saved coverage threshold, so the cardiovascular connection is narrow.

Evidence88

Coenzyme Q10 leads the saved evidence finding, with limitations from the supplied populations and outcomes.
Evidence strength
Coenzyme Q10 has the strongest included evidence finding at its declared amount; the finding does not demonstrate cardiovascular-event prevention.
Studied preparation
The preparations of ingredients meeting the saved amount threshold match the comparison; this does not prove benefit for the finished formula.

Formulation logic100

The included ingredients have no unmet partner requirement or configured conflict. CoQ10 meets the saved amount threshold.
Partner coverage
Every included ingredient can contribute alone or has the partner required by the saved comparison.
Conflicts
No configured ingredient conflict was identified; this is not an assessment of all possible interactions.
Effective doses
CoQ10 meets the saved amount threshold.
Study evidence
Metabolism Support
Impact
High effect
B- Ingredient FitF PathwaysB- EvidenceA+ Formulation Logic
Coenzyme Q-10 · 100 mg

Coenzyme Q10 helps mitochondria transfer energy as part of normal cell function. That role does not establish that this serving raises whole-body energy expenditure. The supplied metabolic-control findings concern a different outcome, and neither a durable fat-loss effect nor an advantage of a particular CoQ10 form is established.

How this product is rated for Metabolism Support

Ingredient fit73

Coenzyme Q-10 supplies the product's counted contribution, with partial amount allowance in the saved comparison.
Goal fit
Coenzyme Q-10 is the sole credited ingredient; the product is also linked to other goals.
Dose adequacy
Declared amounts receive partial allowance against the comparison amounts; this does not identify a proven effective dose.

Pathways17

The saved findings mainly concern mitochondrial energy and fat oxidation, with limited breadth across other routes.
Depth
The strongest represented route is mitochondrial energy and fat oxidation; this describes the saved ingredient mapping, not a measured rise in energy expenditure.
Breadth
No route reaches the comparison's coverage threshold.

Evidence75

The retained findings must be interpreted alongside the distinction between ordinary metabolic roles and a demonstrated increase in energy expenditure.
Evidence strength
CoQ10's mitochondrial role does not establish increased whole-body energy expenditure.
Studied preparation
The saved findings accept the counted preparations; this does not establish that this exact product or combination increased energy expenditure.

Formulation logic100

The retained ingredients meet the amount check and have no missing required partners. No evaluated ingredient conflict was triggered.
Partner coverage
No required partner is missing among the counted ingredients; this does not establish extra benefit from combining them.
Conflicts
None of the evaluated ingredient conflicts was triggered.
Effective doses
All ingredients retained for this check meet its amount threshold; the threshold is not a proven clinical minimum.
Study evidence
Inflammation
Impact
High effect
C+ Ingredient FitF PathwaysA EvidenceA+ Formulation Logic
Coenzyme Q-10 · 100 mg

Coenzyme Q-10 supports mitochondrial and antioxidant processes. Its anti-inflammatory relevance comes from a small ubiquinone trial in statin-treated coronary disease, where one inflammatory marker improved but CRP and IL-6 did not. This serving is below the trial's 300 mg daily exposure, so the amount does not establish the same response.

How this product is rated for Inflammation

Ingredient fit66

Coenzyme Q-10 is the sole credited ingredient, though linked to several goals.
Goal fit
Coenzyme Q-10 is the sole credited ingredient, though linked to several goals.
Dose adequacy
The 100 mg serving provides limited amount-based support relative to the studied ubiquinone exposure.

Pathways13

Oxidative and mitochondrial stress is the main area represented. Coverage of other areas is limited.
Depth
Oxidative and mitochondrial stress is the strongest area in the saved findings; this mapping does not establish a clinical effect.
Breadth
No pathway reaches the saved threshold for substantial coverage.

Evidence93

Coenzyme Q-10 leads the saved evidence finding. The preparation is recognized, while the clinical limitations described above still apply.
Evidence strength
Coenzyme Q-10 leads the saved evidence finding; this does not establish routine clinical anti-inflammatory benefit.
Studied preparation
The saved findings recognize the preparations of all credited ingredients; this does not establish equivalence for every clinical outcome.

Formulation logic100

The credited ingredients have no unmet partner requirement or matched conflict in the saved findings. Their amounts clear the threshold used for inclusion.
Partner coverage
Each credited ingredient can contribute independently or has its required partner.
Conflicts
No configured conflict was matched; this is limited to the combinations evaluated.
Effective doses
All credited ingredients clear the amount threshold used for inclusion; this is not proof of an effective clinical dose.
Study evidence

Ingredients

IngredientAmount per servingScore
Coenzyme Q10 (Ubiquinone)
100 mg 67
Gluten Free Adults 18–50 Dairy Free
Report overview
D Active Ingredient Quality & BioavailabilityB- Dose, Safety & Label TransparencyA+ Value
Report alternatives

Sources

Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.

  1. Effects of Coenzyme Q10 Supplementation on Lipid Profiles in Adults: A Meta-analysis of Randomized Controlled Trials.
    Liu Z; Tian Z; Zhao D; Liang Y; Dai S; Liu M; Hou S; Dong X; Zhaxinima; Yang Y · The Journal of clinical endocrinology and metabolism · 2022
    Meta-analysis2,794 participants50 studies pooledCardiovascular Support Heart Health forCoenzyme Q-10
  2. Six-month supplementation with high dose coenzyme Q10 improves liver steatosis, endothelial, vascular and myocardial function in patients with metabolic-dysfunction associated steatotic liver disease: a randomized double-blind, placebo-controlled trial.
    Vrentzos E; Ikonomidis I; Pavlidis G; Katogiannis K; Korakas E; Kountouri A; Pliouta L; Michalopoulou E; Pelekanou E; Boumpas D; Lambadiari V · Cardiovascular diabetology · 2024
    Randomized trial60 participantsCardiovascular Support forCoenzyme Q-10
  3. The effect of coenzyme Q10 on morbidity and mortality in chronic heart failure: results from Q-SYMBIO: a randomized double-blind trial.
    Mortensen SA; Rosenfeldt F; Kumar A; Dolliner P; Filipiak KJ; Pella D; Alehagen U; Steurer G; Littarru GP; Q-SYMBIO Study Investigators · JACC. Heart failure · 2015
    Randomized trial420 participantsCardiovascular Support forCoenzyme Q-10
  4. [Coenzyme Q-10 in the treatment of patients with chronic heart failure and reduced left ventricular ejection fraction: systematic review and meta-analysis].
    Mareev VY; Mareev YV; Begrambekova YL · Kardiologiia · 2022
    Meta-analysis1,139 participants6 studies pooledCardiovascular Support forCoenzyme Q-10
  5. Effect of coenzyme Q10 in Europeans with chronic heart failure: A sub-group analysis of the Q-SYMBIO randomized double-blind trial.
    Mortensen AL; Rosenfeldt F; Filipiak KJ · Cardiology journal · 2020
    Randomized trialCardiovascular Support forCoenzyme Q-10
  6. Effects of Coenzyme Q10 on Statin-Induced Myopathy: An Updated Meta-Analysis of Randomized Controlled Trials.
    Qu H; Guo M; Chai H; Wang WT; Gao ZY; Shi DZ · Journal of the American Heart Association · 2019
    Meta-analysis575 participants12 studies pooledEnergy forCoenzyme Q-10
  7. Coenzyme Q10 Supplementation in Athletes: A Systematic Review.
    Fernandes MSS; Fidelis DEDS; Aidar FJ; Badicu G; Greco G; Cataldi S; Santos GCJ; de Souza RF; Ardigò LP · Nutrients · 2026
    Systematic review16 studies pooledEnergy forCoenzyme Q-10
  8. Effectiveness of Coenzyme Q10 Supplementation for Reducing Fatigue: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Tsai IC; Hsu CW; Chang CH; Tseng PT; Chang KV · Frontiers in pharmacology · 2024
    Meta-analysis1,126 participants13 studies pooledEnergy forCoenzyme Q-10
  9. Antifatigue effects of coenzyme Q10 during physical fatigue.
    Mizuno K; Tanaka M; Nozaki S; Mizuma H; Ataka S; Tahara T; Sugino T; Shirai T; Kajimoto Y; Kuratsune H; Kajimoto O; Watanabe Y · Nutrition (Burbank, Los Angeles County, Calif.) · 2008
    Randomized trial17 participantsEnergy forCoenzyme Q-10
  10. Effect of coenzyme Q10 supplementation on fatigue: A systematic review of interventional studies.
    Mehrabani S; Askari G; Miraghajani M; Tavakoly R; Arab A · Complementary therapies in medicine · 2019
    Systematic review16 studies pooledEnergy forCoenzyme Q-10
  11. Ubiquinol Ameliorates Endothelial Dysfunction in Subjects with Mild-to-Moderate Dyslipidemia: A Randomized Clinical Trial.
    Sabbatinelli J; Orlando P; Galeazzi R; Silvestri S; Cirilli I; Marcheggiani F; Dludla PV; Giuliani A; Bonfigli AR; Mazzanti L; Olivieri F; Antonicelli R; Tiano L · Nutrients · 2021
    Randomized trial51 participantsHeart Health forCoenzyme Q-10
  12. Dose-Response Effect of Coenzyme Q10 Supplementation on Blood Pressure among Patients with Cardiometabolic Disorders: A Grading of Recommendations Assessment, Development, and Evaluation (GRADE)-Assessed Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Zhao D; Liang Y; Dai S; Hou S; Liu Z; Liu M; Dong X; Zhan Y; Tian Z; Yang Y · Advances in nutrition (Bethesda, Md.) · 2022
    Meta-analysis1,831 participants26 studies pooledHeart Health forCoenzyme Q-10
  13. Effects of Coenzyme Q10 on Lipid, Glycemic, and Inflammatory Markers in Metabolic Disorders: A Systematic Review and Meta-Analysis.
    Zhang Z; Liu Z; Geng Y; Huang Y; Hu R; Li F; Song Y; Zhang M · Journal of diabetes research · 2026
    Meta-analysis3,422 participants64 studies pooledHeart Health Metabolism Support forCoenzyme Q-10
  14. Treatment of coenzyme Q10 for 24 weeks improves lipid and glycemic profile in dyslipidemic individuals.
    Zhang P; Yang C; Guo H; Wang J; Lin S; Li H; Yang Y; Ling W · Journal of clinical lipidology · 2019
    Randomized trial101 participantsHeart Health forCoenzyme Q-10
  15. The effect of coenzyme Q10 supplementation on inflammatory and endothelial dysfunction markers in overweight/obese polycystic ovary syndrome patients.
    Taghizadeh S; Izadi A; Shirazi S; Parizad M; Pourghassem Gargari B · Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology · 2021
    Randomized trial43 participantsInflammation forCoenzyme Q-10
  16. The effects of coenzyme Q10 supplementation on metabolic profiles and parameters of mental health in women with polycystic ovary syndrome.
    Karamali M; Gholizadeh M · Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology · 2022
    Randomized trial55 participantsInflammation forCoenzyme Q-10
  17. Efficacy and Optimal Dose of Coenzyme Q10 Supplementation on Inflammation-Related Biomarkers: A GRADE-Assessed Systematic Review and Updated Meta-Analysis of Randomized Controlled Trials.
    Hou S; Tian Z; Zhao D; Liang Y; Dai S; Ji Q; Fan Z; Liu Z; Liu M; Yang Y · Molecular nutrition & food research · 2023
    Meta-analysis1,517 participants31 studies pooledInflammation forCoenzyme Q-10
  18. Can coenzyme Q10 supplementation effectively reduce human tumor necrosis factor-α and interleukin-6 levels in chronic inflammatory diseases? A systematic review and meta-analysis of randomized controlled trials.
    Farsi F; Heshmati J; Keshtkar A; Irandoost P; Alamdari NM; Akbari A; Janani L; Morshedzadeh N; Vafa M · Pharmacological research · 2020
    Meta-analysis509 participants9 studies pooledInflammation forCoenzyme Q-10
  19. Promising efficacy of coenzyme Q10 supplementation as adjunctive therapy in juvenile idiopathic arthritis: a randomized-controlled pilot study.
    Elsherif N; Shousha G; Sabri NA; Shawki MA · Immunopharmacology and immunotoxicology · 2026
    Randomized trial58 participantsInflammation forCoenzyme Q-10
  20. Coenzyme Q10 and Degenerative Disorders Affecting Longevity: An Overview.
    Mantle D; Hargreaves I · Antioxidants (Basel, Switzerland) · 2020
    Narrative reviewLongevity forCoenzyme Q-10